EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Zeste White 10 May Serve as a Prognostic Biomarker and Therapeutic Target for Human Breast Cancer

Sm Faysal Bellah iD, Md Alim Hossen, Sm Saker Billah, Olanrewaju Ayodeji Durojaye, Md Obayed Raihan

Breast Cancer: Basic and Clinical Research · 2026-03 · 20

DOI: 10.1177/11782234261428784 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Cancer: Basic and Clinical Research, online erschienen am 11.03.2026. Verfasst von Sm Faysal Bellah und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Pabna University of Science and Technology, Pabna-6600, Bangladesh. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Zeste White 10 (ZW10) is a key component of the spindle assembly checkpoint (SAC) that maintains chromosomal stability during mitosis. Dysregulation of ZW10 can cause chromosomal instability and aneuploidy—hallmarks of many cancers, including breast cancer, particularly triple-negative breast cancer (TNBC). However, its prognostic and therapeutic relevance in breast cancer remains unclear.

Objectives

This study aimed to systematically investigate the expression pattern, prognostic significance, mutational profile, and immune associations of ZW10 in breast cancer using integrated omics data.

Design

A computational, cross-cohort bioinformatics analysis combining transcriptomic, proteomic, mutational, and clinical data from publicly available databases.

Methods

The ZW10 expression levels were assessed across normal and cancerous tissues using The Cancer Genome Atlas (TCGA), Genotype-Tissue Expression (GTEx), and the Human Protein Atlas data sets. Immune infiltration correlations were analyzed using TIMER2.0, Gene Set Cancer Analysis (GSCA), and TNMplot. Survival analyses were performed using Kaplan-Meier Plotter and TCGA clinical data sets. Protein-protein interaction (PPI) and functional enrichment analyses were conducted using STRING and EnrichR, and mutation data were retrieved from COSMIC and cBioPortal.

Results

The ZW10 expression was markedly upregulated across multiple cancers, with the highest expression in TNBC. Elevated ZW10 levels correlated with immune cell infiltration and adverse overall survival, while lower ZW10 expression predicted improved relapse-free survival. Protein-protein interaction and enrichment analyses revealed ZW10’s close interaction with key mitotic regulators and its involvement in spindle checkpoint and vesicular trafficking pathways. Mutation analysis identified predominant A > G and A > T substitutions and frequent gene amplifications across malignancies.

Conclusion

The ZW10 acts as a potential prognostic biomarker and therapeutic target in breast cancer, particularly TNBC, through its dual roles in mitotic regulation and immune modulation. Further experimental validation is warranted to confirm its mechanistic role and therapeutic potential.

Schlagwörter

Stichwörter der Autor:innen

TCGAZW10breast cancermitotic checkpointprognosistriple-negative breast cancer

Autor:innen und Institutionen

  • Department of Pharmacy, Pabna University of Science and Technology, Pabna-6600, Bangladesh.
  • Department of Physical Sciences, Independent University, Bangladesh, Dhaka 1229, Bangladesh.
  • Bioinformatics Lab, Department of Statistics, University of Rajshahi, Rajshahi-6205, Bangladesh.
  • Department of Chemistry, National University, Gazipur-1704, Bangladesh.
  • Drug Discovery and Biotechnology Unit, Lion Science Park, University of Nigeria, Nsukka, 410001, Nigeria.
  • Department of Chemical Sciences, Coal City University, Emene, Enugu State, Nigeria.

ORCID-Profile: Sm Faysal Bellah

Zitieren

APA

Bellah, S. F., Hossen, M. A., Billah, S. S., Durojaye, O. A., & Raihan, M. O. (2026). Zeste White 10 May Serve as a Prognostic Biomarker and Therapeutic Target for Human Breast Cancer. Breast Cancer: Basic and Clinical Research, 20. https://doi.org/10.1177/11782234261428784

Vancouver

Bellah SF, Hossen MA, Billah SS, Durojaye OA, Raihan MO. Zeste White 10 May Serve as a Prognostic Biomarker and Therapeutic Target for Human Breast Cancer. Breast Cancer: Basic and Clinical Research. 2026;20. doi:10.1177/11782234261428784

BibTeX
@article{Bellah2026,
  author = {Bellah, Sm Faysal and Hossen, Md Alim and Billah, Sm Saker and Durojaye, Olanrewaju Ayodeji and Raihan, Md Obayed},
  title = {Zeste White 10 May Serve as a Prognostic Biomarker and Therapeutic Target for Human Breast Cancer},
  journal = {Breast Cancer: Basic and Clinical Research},
  year = {2026},
  volume = {20},
  doi = {10.1177/11782234261428784}
}
Kostenlos starten →